Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
2,499 people get AFFY articles and Market Currents by email alert.
Get email alerts on AFFY »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
Business Wire (Jun 6, 2013)
-
at MarketWatch.com (Jun 3, 2013)
-
at CNBC.com (May 31, 2013)
-
at MarketWatch.com (Apr 2, 2013)
-
Business Wire (Apr 2, 2013)
-
at MarketWatch.com (Mar 19, 2013)
-
at CNBC.com (Mar 19, 2013)
-
at CNBC.com (Mar 19, 2013)
-
Business Wire (Mar 18, 2013)
-
at MarketWatch.com (Feb 25, 2013)
-
at MarketWatch.com (Feb 25, 2013)
-
at MarketWatch.com (Feb 25, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 6, 2013)
-
Business Wire (Feb 1, 2013)
-
Business Wire (Jan 7, 2013)
-
Business Wire (Jan 3, 2013)
-
Business Wire (Jan 3, 2013)
-
Business Wire (Nov 20, 2012)
AFFY vs. ETF Alternatives
Company Description
Currently, there's no company description for AFFY.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Wednesday, June 12, 12:45 PM
Midday top 10 gainers: CERE +73%. CTB +41%. SGOC +28%. ULTA +17%. GPRC +14%. SE +10%. UQM +9%. AFFY +9%. AMED +9%. HMA +9%.
Midday top 10 Losers: IQNT -17%. KNDI -17%. CLSN -14%. TELK -12%. RLOG -12%. VRTB -11%. OSH -11%. CBAK -11%. ECTE -10%. CTC -10%. 1 Comment [On the Move] -
Monday, June 10, 12:45 PM
Midday top 10 gainers: SGOC +25%. ACAD +17%. STEL +17%. MPAA +14%. TRMD +9%. OVAS +13%. CLIR +13%. TPLM +12%. RVLT +13%. KNDI +12%.
Midday top 10 Losers: DVAX -35%. OSH -18%. ECTE -16%. AFFY -14%. AEPI -14%. OMX -12%. SHI -12%. PLM -11%. GNRC -11%. CBAK -11%. 1 Comment [On the Move] -
Friday, June 7, 12:45 PM
Midday top 10 gainers: OSH +23%. WSBF +19%. OPTT +17%. CSFS +14%. BDBD +13%. JKS +11%. ROSG +11%. THO +10%. ECTY +10%. KFS +9%.
Midday top 10 Losers: FSGI -56%. TIVO -17%. USM -17%. IRM -16%. ZQK -12%. JRCC -11%. LQDT -11%. AFFY -10%. CBPO -10%. TRUE -8%. Comment! [On the Move] - Wednesday, June 5, 11:12 AM Affymax (AFFY -3.8%) takes a bit of mid-day pressure ahead of its pending delisting from the Nasdaq tomorrow. The company plans to list on the OTCBB. The company was notified by regulators late last week that it was operating as a "public shell" and following the voluntary recall of Omontys, it no longer has an operating business. 1 Comment [Healthcare, On the Move]
- Monday, June 3, 12:48 PM Midday top 10 gainers: CLVS +124%. OSH +62%. FALC +35%. TSRO +31%. ASI +21%. CHTP +19%. RCPT +18%. FLML +17%. LPTH +17%. PXLW +16%. Midday top 10 Losers: SNTA -34%. INFI -26%. SCON -20%. AFFY -19%. NBG -15%. GIGA -12%. P -11%. XONE -10%. DQ -10%. PW -10%. Comment!
- Monday, June 3, 12:43 PM Affymax (AFFY -19.3%) will be delisted by Nasdaq at the close of Wednesday's trading, after the biotech developer declined to appeal a ruling that "the company no longer has an operating business" and is instead a "public shell" due to the recall of its anemia drug Omontys. The company also announced that it was paying out $6M to two suppliers of the drug's ingredients. Comment! [Healthcare, On the Move]
-
Monday, June 3, 9:13 AM
Premarket gainers: ASI +21%. TEAR +11%. PPHM +12%. OSH +9%. CLP +7%. MTL +6%. SODA +5%. INFY +5%.
Losers: AFFY -27%. INFI -16%. NBG -13%. SNTA -12%. Comment! [On the Move] - Friday, May 31, 5:01 PM Affymax (AFFY) says it's received a determination letter from Nasdaq indicating that it believes it should be delisted. Specifically, Nasdaq notified AFFY that it's operating as a “public shell,” since its voluntary recall of Omontys means the company essentially no longer has an operating business. AFFY doesn't plan to appeal. Shares -22% AH. 5 Comments [Healthcare, On the Move]
- Friday, May 31, 4:00 PM Shares of Affymax (AFFY +31.5%) soar today on the back of what appears to be a massive short squeeze. The most recent data on the stock has short interest rising 43% from the start to middle of May, with around 18.5M shares currently out on loan, or 50% of its float. 1 Comment [Healthcare, On the Move]
-
Friday, May 31, 9:14 AM
Premarket gainers: OVTI +21%. NBG +19%. AFFY +8%. CLSN +8%. KKD +7%. ETRM +6%. LEDS +6%. GES +5%.
Losers: PANW -13%. PLM -12%. MHGC -7%. NMR -6%. Comment! [On the Move] -
Wednesday, May 15, 9:14 AM
Premarket gainers: CHCI +41%. DVR +25%. CLNT +14%. VIPS +13%. EJ +11%. AFFY +9%. CHLN +9%. SPWR +8%. AVEO +5%.
Losers: XONE -10%. RMTI -8%. WMC -5%. 2 Comments [On the Move] - Tuesday, May 14, 6:20 PM Affymax (AFFY) says that in connection with ongoing restructuring efforts, it's terminating John Orwin's tenure as CEO effective tomorrow. The board will be replacing him, as well as a number of other company officers, with representatives from its restructuring firm, The Brenner Group, in the coming weeks. Orwin will remain on the Board of Directors. Shares +0.7% AH. 2 Comments [Healthcare]
-
Monday, May 13, 9:10 AM
Premarket gainers: UNIS +25%. SUTR +20%. THRX +13%. PERI +13%. NBG +11%. IGLD +10%. TSLA +6%. CSIQ +5%. SPWR +5%.
Losers: AFFY -8%. UNXL -5%. Comment! [On the Move] -
Friday, May 10, 12:52 PM
Midday top 10 gainers: UNIS +58%. DRAM +57%. VRML +26%. SREV +22%. MCP +20%. UBNT +18%. RH +18%. WCRX +17%. CSIQ +16%. SQNM +16%.
Midday top 10 losers: PTIE -48%. DRRX -41%. IFMI -34%. AFFY -26%. SRT -23%. LPDX -22%. OPTR -17%. REFR -16%. PANL -16%. TRMD -15%. Comment! [On the Move] -
Friday, May 10, 9:10 AM
Premarket gainers: PGNX +26%. UNIS +21%. UBNT +19%. SQNM +11%. MCP +11%. XIN +7%. NBG +6%. NTE +5%. MT +5%.
Losers: PTIE -48%. IFMI -36%. AFFY -18%. SNTS -7%. OPTR -7%. DDD -6%. MDRX -6%. LFVN -5%. Comment! [On the Move] -
Thursday, May 9, 12:46 PM
Midday top 10 gainers: TRMD +94%. OPTT +42%. VRML +32%. AFFY +28%. TSLA +27%. XOMA +26%. GMCR +25%. CTRP +24%. OWW +23%. CHYR +19%.
Midday top 10 losers: LPSN -34%. PZZI -33%. RAX -26%. KEM -25%. NSYS -23%. MNOV -22%. WG -20%. GV -18%. ORBT -16%. OFIX -16%. Comment! [On the Move]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.


















